Active substance
Magnesium chloride
- Health Canada 2
- Safety 6
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| MAGNESIUM CHLORIDE FOR HEMODIALYSIS 5.15 | 02528193 | 5.15 G / VIAL | POWDER FOR SOLUTION · HAEMODIALYSIS | CHIEF MEDICAL SUPPLIES LTD |
| MAGNESIUM-45 0.5-4.5 | 02219301 | 20.5 G / BOTTLE | POWDER FOR SOLUTION · HAEMODIALYSIS | VANTIVE ULC |
Safety signals and safety-related labeling changes
- US FDA 5 Aug 2019 PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations - US FDA 5 Aug 2019 PLASMA-LYTE A IN PLASTIC CONTAINER — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations - US FDA 1 May 2019 NORMOCARB HF 25 — safety-related labeling change
Labeling sections changed: Use in Specific Populations - US FDA 1 May 2019 NORMOCARB HF 35 — safety-related labeling change
Labeling sections changed: Use in Specific Populations - US FDA 30 Jun 2017 PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations - US FDA 30 Jun 2017 PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations
Combinations containing Magnesium chloride
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.